Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema
Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema
View: Text | PDF
Research Article Cell biology Development

Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development

  • Text
  • PDF
Abstract

Ongoing societal changes in views on the medical and recreational roles of cannabis increased the use of concentrated plant extracts with a Δ9-tetrahydrocannabinol (THC) content of more than 90%. Even though prenatal THC exposure is widely considered adverse for neuronal development, equivalent experimental data for young age cohorts are largely lacking. Here, we administered plant-derived THC (1 or 5 mg/kg) to mice daily during P5–P16 and P5–P35 and monitored its effects on hippocampal neuronal survival and specification by high-resolution imaging and iTRAQ proteomics, respectively. We found that THC indiscriminately affects pyramidal cells and both cannabinoid receptor 1+ (CB1R)+ and CB1R– interneurons by P16. THC particularly disrupted the expression of mitochondrial proteins (complexes I–IV), a change that had persisted even 4 months after the end of drug exposure. This was reflected by a THC-induced loss of membrane integrity occluding mitochondrial respiration and could be partially or completely rescued by pH stabilization, antioxidants, bypassed glycolysis, and targeting either mitochondrial soluble adenylyl cyclase or the mitochondrial voltage-dependent anion channel. Overall, THC exposure during infancy induces significant and long-lasting reorganization of neuronal circuits through mechanisms that, in large part, render cellular bioenergetics insufficient to sustain key developmental processes in otherwise healthy neurons.

Authors

Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema

×

Figure 1

THC exposure during P5–P16 induces neurochemical deficits in CA1 hippocampal neurons.

Options: View larger image (or click on image) Download as PowerPoint
THC exposure during P5–P16 induces neurochemical deficits in CA1 hippoca...
(A) Experimental paradigm in CCKBAC/DsRed and CckBAC/DsRedGad1gfp/+ mice. Daily injections had an average volume of 100 μL, but final volume was adjusted to the individual body weight; n = 3–8 mice/genotype/treatment (n = 3–4 mice/treatment for CckBAC/DsRedGad1gfp/+ line). (B) Schematic outline of the dorsal hippocampus, with red circles denoting the localization of DsRed+ neurons. (C) Representative images from DsRed+/GFP+ hippocampi after vehicle or THC treatment. Vertical bar over the pyramidal layer shows the general approach to measure cell spread within. Solid arrowheads point to DsRed+/GFP+ interneurons in control, whereas open arrowheads denote residual cells upon THC exposure. Arrows point to small-diameter DsRed+ neurons at the deep stratum lacunosum moleculare (slm; see also Supplemental Figure 3A). (D) High-resolution image of pyramidal cells in hippocampal CA1, with vertical bar illustrating a vector to measure cell spread (left) with quantitative data (right). (E) DsRed+/GFP+ neurons in slm. Arrows point to small-diameter DsRed+ signal. (F and G) The density of DsRed+ (F) but not GFP+ neurons (G) significantly decreased in nonpyramidal layers of the CA1 subfield (qualifying as interneurons by location) after THC treatment. (H) Likewise, the density of DsRed+/GFP+ interneurons in strata alveus/oriens (but not of the GFP+ neuronal contingent) became significantly reduced upon THC treatment. (I) Similar changes were seen in stratum lacunosum moleculare. (J) Representative photomicrograph showing the distribution of Pvalb+/GFP+ interneurons in nonpyramidal CA1. (K) THC-induced dose-dependent changes in Pvalb+ interneuron density in stratum oriens. Note that THC treatment did not affect the probability of Pvalb and GFP colocalization. (L) Histochemical detection of Sst+ interneurons in the hippocampus. (M) THC induced dose-dependent changes in the density of but not the probability of colocalization with GFP for Sst+ interneurons. Cell counts were normalized to a surface area of 1 mm2. Data were expressed as mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 (versus control; 1-way ANOVA followed by Bonferroni’s post hoc test). Scale bars: 120 μm (C), 25 μm (D and E), 10 μm (J and L). str., striatum; alv, str. alveus; dg, dentate gyrus; or, str. oriens; PFA, paraformaldehyde; pyr, str. pyramidale; rad, str. radiatum.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts